loadpatents
name:-0.066498994827271
name:-0.017944097518921
name:-0.00055289268493652
Eastwood; Paul Robert Patent Filings

Eastwood; Paul Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eastwood; Paul Robert.The latest application filed is for "pyrazole derivatives as jak inhibitors".

Company Profile
0.18.28
  • Eastwood; Paul Robert - Barcelona ES
  • Eastwood; Paul Robert - Sant Feliu de Llobregat ES
  • Eastwood; Paul Robert - Rubi N/A ES
  • Eastwood; Paul Robert - Romford GB
  • Eastwood; Paul Robert - Dagenham GB
  • Eastwood, Paul Robert - West Malling GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors
Grant 9,206,183 - Bach Tana , et al. December 8, 2
2015-12-08
Pyridin-2(1 H)-one derivatives as JAK inhibitors
Grant 9,034,311 - Eastwood , et al. May 19, 2
2015-05-19
Pyrazole Derivatives As Jak Inhibitors
App 20150118186 - BACH TANA; Jordi ;   et al.
2015-04-30
Pyridin-2(1h)-one Derivatives As Jak Inhibitors
App 20140271543 - Eastwood; Paul Robert ;   et al.
2014-09-18
Substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors
Grant 8,772,288 - Eastwood , et al. July 8, 2
2014-07-08
Pyridin-2(1h)-one Derivatives Useful As Medicaments For The Treatment Of Myeloproliferative Disorders, Transplant Rejection, Immune-mediated And Inflammatory Diseases
App 20140170110 - Eastwood; Paul Robert ;   et al.
2014-06-19
Pyrazole Derivatives As Jak Inhibitors
App 20140086870 - Bach Tana; Jordi ;   et al.
2014-03-27
Imidazopyridine Derivatives As Jak Inhibitors
App 20130216498 - Eastwood; Paul Robert ;   et al.
2013-08-22
Pyrazole Derivatives As Jak Inhibitors
App 20130209400 - Bach Tana; Jordi ;   et al.
2013-08-15
Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
Grant 8,450,341 - Eastwood , et al. May 28, 2
2013-05-28
Heteroaryl Imidazolone Derivatives As Jak Inhibitors
App 20130089512 - Eastwood; Paul Robert ;   et al.
2013-04-11
4,8-diphenyl-polyazanaphthalene derivatives
Grant 8,334,294 - Lumeras Amador , et al. December 18, 2
2012-12-18
3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
Grant 8,258,122 - Vidal Juan , et al. September 4, 2
2012-09-04
Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)
Grant 8,008,491 - Jiang , et al. August 30, 2
2011-08-30
Substituted Spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one Derivatives And Their Use As P38 Mitogen-activated Kinase Inhibitors
App 20110053936 - Eastwood; Paul Robert ;   et al.
2011-03-03
Substituted Indolin-2-one Derivatives And Their Use As P38 Mitogen-activated Kinase Inhibitors
App 20110046097 - Eastwood; Paul Robert ;   et al.
2011-02-24
Imidazopyridine derivatives as A.sub.2B adenosine receptor antagonists
Grant 7,855,202 - Vidal Juan , et al. December 21, 2
2010-12-21
Pyrazine Derivatives Useful As Adenosine Receptor Antagonists
App 20100273757 - Vidal Juan; Bernat ;   et al.
2010-10-28
Pyrazine derivatives useful as adenosine receptor antagonists
Grant 7,790,728 - Vidal Juan , et al. September 7, 2
2010-09-07
New 4,8-diphenyl-polyazanaphthalene Derivatives
App 20100130517 - Lumeras Amador; Wenceslao ;   et al.
2010-05-27
3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide Derivatives
App 20100120731 - Vidal Juan; Bernat ;   et al.
2010-05-13
Substituted bis aryl and heteroaryl compounds as selective 5HT.sub.2A antagonists
Grant 7,625,889 - Eastwood , et al. December 1, 2
2009-12-01
Pyrazine Derivatives Useful as Adenosine Receptor Antagonists
App 20090042891 - Vidal Juan; Bernat ;   et al.
2009-02-12
Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists
App 20090023763 - Vidal Juan; Bernat ;   et al.
2009-01-22
Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
App 20080275038 - Vidal Juan; Bernat ;   et al.
2008-11-06
Substituted Aza-indoles As Inhibitors Of Poly(adp-ribose) Polymerase (parp)
App 20080255350 - JIANG; John Z. ;   et al.
2008-10-16
Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
Grant 7,405,300 - Jiang , et al. July 29, 2
2008-07-29
Substituted Bis Aryl And Heteroaryl Compounds As Selective 5ht2a Antagonists
App 20070265309 - EASTWOOD; Paul Robert ;   et al.
2007-11-15
Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
App 20050054631 - Jiang, John Z. ;   et al.
2005-03-10
Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
Grant 6,706,738 - Clark , et al. March 16, 2
2004-03-16
Substituted ureas
Grant 6,620,832 - Eastwood September 16, 2
2003-09-16
Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
App 20020173506 - Clark, David Edward ;   et al.
2002-11-21
Substituted anilides
Grant 6,479,519 - Astles , et al. November 12, 2
2002-11-12
Substituted bicyclic compounds
App 20020156111 - Clark, David Edward ;   et al.
2002-10-24
Substituted bicyclic compounds
App 20020137782 - Clark, David Edward ;   et al.
2002-09-26
Substituted ureas
App 20020082255 - Eastwood, Paul Robert
2002-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed